Currently, bone and bone fragments with valuable stem cells are disposed as waste material during fracture-related routine operations. However, these stem cells have a high potential for regenerative therapies as for instance in the treatment of bone fractures.
BONEBANK aims at harvesting these stem cells with new instruments and methods and to store them in a cross-border biobank.

Therefore, this useful resource can be used for therapeutic purposes or for the development of new therapies.


Usage of Results

BONEBANK addresses various target audiences:

  • Clinicians and hospitals implement the BONEBANK approach to harvest bone marrow stem cells during routine operations.
  • Public and/ or private biobank operators are part of the BONEBANK value chain to store and market stem cells.
  • Public researchers use bone marrow stem cells for research purposes.
  • Life Science Industry (Medtech, Biotech, Pharma) purchase bone marrow stem cells for research and the development of therapies.
  • Politicians and general public understand the potentials of bone marrow stem cells for regenerative medicine and the value of the BONEBANK network for the cross-border region.
© psdesign1 / Fotolia
© psdesign1 / Fotolia
© ICB-Lübeck
© ICB-Lübeck

Usage of Stem Cells

BONEBANK creates the preconditions for a diverse field of applications of stem cells in the process of bone healing:

  • Own use by patients
  • Donation for other patients
  • Storage for future own use or for use by immediate family members
  • Basic research for the benefit of the general public
  • Development of personalised diagnostics, drug development and therapies in the German-Danish border region